Trial NCT00219765

View at ClinicalTrials.gov 
Org. Study IDs: 010495
Secondary IDs: CSTI571AFR01

Last trial update was posted on 2005-11-28

MeSH Interventions

Cytarabine Daunorubicin Imatinib Mesylate

MeSH Conditions

Leukemia Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Other Conditions

Chronic Myeloid Leukemia

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID